MedPath

IRCCS SAN RAFFAELE ROMA SRL

🇮🇹Italy
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.poliambulatorisanraffaele.it/it/sedi/san-raffaele-pisana

Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk

Completed
Conditions
Diabetes Mellitus, Type 2
First Posted Date
2007-08-27
Last Posted Date
2007-08-27
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
1997
Registration Number
NCT00520962
Locations
🇮🇹

Medicine Division, Diabetology, Endocrinology and Metabolic Disease Unit, IRCCS San Raffaele, Milan, Italy

Testosterone Improves Exercise Oxygen Uptake, Insulin Resistance and Muscle Strength in Elderly Patients With Chronic Heart Failure

Terminated
Conditions
Congestive Heart Failure
Interventions
First Posted Date
2007-08-07
Last Posted Date
2008-10-17
Lead Sponsor
IRCCS San Raffaele
Registration Number
NCT00512408
Locations
🇮🇹

IRCCS San Raffaele, Rome, Italy

Nebivolol Versus Carvedilol in Patients With Heart Failure

Terminated
Conditions
Chronic Heart Failure
Hypertension
First Posted Date
2007-08-06
Last Posted Date
2008-10-17
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
160
Registration Number
NCT00511888
Locations
🇮🇹

IRCCS San Raffaele, Rome, Italy

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Phase 3
Conditions
HIV Infections
Hepatitis C
Interventions
Drug: LPV/r
Drug: Nucleoside Reverse Transcriptase Inhibitors
Drug: PEG-IFNa 2a
First Posted Date
2007-02-21
Last Posted Date
2009-02-06
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
60
Registration Number
NCT00437476
Locations
🇮🇹

San Raffaele Hospital Dep. Infectious Diseases, Milan, Italy

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Phase 3
Conditions
HIV Infections
Hepatitis C
Interventions
Drug: LPV/r
Drug: PEG-IFNa 2a
Drug: NUCS
First Posted Date
2007-02-21
Last Posted Date
2009-02-06
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
50
Registration Number
NCT00437684
Locations
🇮🇹

San Raffaele Hospital, Dep. Infectious Diseases, Milan, Italy

Effect of Chronic PDE5-Inhibition on Endothelial Function in Diabetics

Phase 3
Completed
Conditions
Diabetes
First Posted Date
2007-01-11
Last Posted Date
2007-01-11
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
30
Registration Number
NCT00420901
Locations
🇮🇹

San Raffaele EUR, Roma, Italy

Prevention of Cardiac and Vascular Events in Patients With NGT/IGT.

Phase 3
Completed
Conditions
Cardiovascular Disease
First Posted Date
2006-12-07
Last Posted Date
2006-12-12
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
150
Registration Number
NCT00408577
Locations
🇮🇹

Scientific Institute San Raffaele, Milan, Italy

A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF)

Phase 4
Completed
Conditions
Atrial Fibrillation
First Posted Date
2006-06-21
Last Posted Date
2010-07-28
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
198
Registration Number
NCT00340314
Locations
🇮🇹

San Raffaele University Hospital, Milan, Italy

Electromagnetic Stimulation (FREMS) in Patients With Painful Diabetic Neuropathy

Phase 2
Completed
Conditions
Painful Diabetic Neuropathy
First Posted Date
2006-06-15
Last Posted Date
2006-06-15
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
38
Registration Number
NCT00337324
Locations
🇮🇹

San Raffaele Hospital and Scientific Institute, Milano, (Mi), Italy

Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease

Phase 4
Completed
Conditions
Coronary Artery Disease
Type II Diabetes Mellitus
First Posted Date
2006-01-26
Last Posted Date
2006-01-26
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
30
Registration Number
NCT00282360
© Copyright 2025. All Rights Reserved by MedPath